CD19仿T

Xubin Li1, Jared Henderson1, Max J Gordon1

  • 1Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Cancer cell
|September 22, 2023
PubMed
概括

研究人员分析了从Axicabtagene ciloleucel治疗的复发或耐火性大B细胞淋巴瘤患者的单细胞RNA测序数据. 他们确定了响应者和不响应者之间输液产品的关键差异.

相关概念视频